ASND
Price
$192.02
Change
+$2.28 (+1.20%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
11.49B
48 days until earnings call
CASI
Price
$1.31
Change
-$0.20 (-13.25%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
23.41M
Interact to see
Advertisement

ASND vs CASI

Header iconASND vs CASI Comparison
Open Charts ASND vs CASIBanner chart's image
Ascendis Pharma A/S
Price$192.02
Change+$2.28 (+1.20%)
Volume$12K
Capitalization11.49B
CASI Pharmaceuticals
Price$1.31
Change-$0.20 (-13.25%)
Volume$700
Capitalization23.41M
ASND vs CASI Comparison Chart in %
Loading...
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASND vs. CASI commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a StrongBuy and CASI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ASND: $189.74 vs. CASI: $1.51)
Brand notoriety: ASND and CASI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASND: 72% vs. CASI: 1%
Market capitalization -- ASND: $11.49B vs. CASI: $23.41M
ASND [@Biotechnology] is valued at $11.49B. CASI’s [@Biotechnology] market capitalization is $23.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASND’s FA Score shows that 0 FA rating(s) are green whileCASI’s FA Score has 0 green FA rating(s).

  • ASND’s FA Score: 0 green, 5 red.
  • CASI’s FA Score: 0 green, 5 red.
According to our system of comparison, ASND is a better buy in the long-term than CASI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASND’s TA Score shows that 3 TA indicator(s) are bullish while CASI’s TA Score has 4 bullish TA indicator(s).

  • ASND’s TA Score: 3 bullish, 5 bearish.
  • CASI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ASND and CASI are a bad buy in the short-term.

Price Growth

ASND (@Biotechnology) experienced а -4.83% price change this week, while CASI (@Biotechnology) price change was -15.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +9.50%, and the average quarterly price growth was +52.01%.

Reported Earning Dates

ASND is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASND($11.5B) has a higher market cap than CASI($23.4M). ASND YTD gains are higher at: 37.822 vs. CASI (-46.608). CASI has higher annual earnings (EBITDA): -42.6M vs. ASND (-161.68M). ASND has more cash in the bank: 518M vs. CASI (6.76M). CASI has less debt than ASND: CASI (18.7M) vs ASND (847M). ASND has higher revenues than CASI: ASND (491M) vs CASI (31.6M).
ASNDCASIASND / CASI
Capitalization11.5B23.4M49,145%
EBITDA-161.68M-42.6M380%
Gain YTD37.822-46.608-81%
P/E RatioN/AN/A-
Revenue491M31.6M1,554%
Total Cash518M6.76M7,660%
Total Debt847M18.7M4,529%
FUNDAMENTALS RATINGS
ASND vs CASI: Fundamental Ratings
ASND
CASI
OUTLOOK RATING
1..100
6151
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
68100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4665
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CASI's Valuation (68) in the Biotechnology industry is in the same range as ASND (89). This means that CASI’s stock grew similarly to ASND’s over the last 12 months.

ASND's Profit vs Risk Rating (68) in the Biotechnology industry is in the same range as CASI (100). This means that ASND’s stock grew similarly to CASI’s over the last 12 months.

ASND's SMR Rating (100) in the Biotechnology industry is in the same range as CASI (100). This means that ASND’s stock grew similarly to CASI’s over the last 12 months.

ASND's Price Growth Rating (46) in the Biotechnology industry is in the same range as CASI (65). This means that ASND’s stock grew similarly to CASI’s over the last 12 months.

ASND's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CASI (100). This means that ASND’s stock grew similarly to CASI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASNDCASI
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
73%
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WBD19.78-0.04
-0.20%
Warner Bros Discovery
FVRR24.85-0.20
-0.80%
Fiverr International Ltd
ISSC11.86-0.18
-1.50%
Innovative Solutions and Support
MRCY73.13-1.14
-1.53%
Mercury Systems
TRSG1.40-0.04
-2.78%
Tungray Technologies

ASND and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with ZNTL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then ZNTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
-1.83%
ZNTL - ASND
40%
Loosely correlated
-1.97%
ZYME - ASND
37%
Loosely correlated
-0.86%
ORMP - ASND
37%
Loosely correlated
N/A
AMRN - ASND
35%
Loosely correlated
+0.06%
AXON - ASND
34%
Loosely correlated
+2.02%
More

CASI and

Correlation & Price change

A.I.dvisor tells us that CASI and ASND have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CASI and ASND's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CASI
1D Price
Change %
CASI100%
-4.37%
ASND - CASI
33%
Poorly correlated
-1.83%
NEVPF - CASI
31%
Poorly correlated
N/A
BTAI - CASI
29%
Poorly correlated
+9.30%
RIGL - CASI
29%
Poorly correlated
-5.22%
ADCT - CASI
28%
Poorly correlated
-3.09%
More